drugset / Trial / NCT04141904
Tofacitinib in Depression (TIDE)
Phase 1/2
Terminated
2 enrolled
University of Oxford
Medical Research Council · collabWellcome Trust · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study will test whether 7-10 day administration of the anti-inflammatory drug, tofacitinib, has positive effects on people experiencing treatment-resistant depression compared to placebo.
Timeline
- Start
- 2020-02-10
- Primary completion
- 2022-05-23
- Completion
- 2022-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tofacitinib | Small molecule | 5 mg | — |